November 6, 2026

Neng Nana

Becton, Dickinson and Company Hits Enrollment Milestone in Landmark PREVENT Trial for Hernia Prophylaxis becton-dickinson-and-company-hits-enrollment-milestone-in-landmark-prevent-trial-for-hernia-prophylaxis

Becton, Dickinson and Company Hits Enrollment Milestone in Landmark PREVENT Trial for Hernia Prophylaxis

Neng Nana August 13, 2026
In a significant stride toward addressing a common yet debilitating complication of abdominal surgery, Becton, Dickinson and...
Read More Read more about Becton, Dickinson and Company Hits Enrollment Milestone in Landmark PREVENT Trial for Hernia Prophylaxis
A New Era for Preventive Health: Canada Establishes National Advisory Committee to Transform Breast Cancer Outcomes a-new-era-for-preventive-health-canada-establishes-national-advisory-committee-to-transform-breast-cancer-outcomes

A New Era for Preventive Health: Canada Establishes National Advisory Committee to Transform Breast Cancer Outcomes

Neng Nana August 13, 2026
OTTAWA — In a move hailed as a pivotal milestone for Canadian public health, the Government of...
Read More Read more about A New Era for Preventive Health: Canada Establishes National Advisory Committee to Transform Breast Cancer Outcomes
The "Triple-G" Crisis: Eli Lilly Launches Multi-Front War Against the Black Market for Retatrutide the-triple-g-crisis-eli-lilly-launches-multi-front-war-against-the-black-market-for-retatrutide

The "Triple-G" Crisis: Eli Lilly Launches Multi-Front War Against the Black Market for Retatrutide

Neng Nana August 12, 2026
As Eli Lilly prepares for the high-stakes regulatory filing of its experimental weight-loss powerhouse, retatrutide—often dubbed the...
Read More Read more about The "Triple-G" Crisis: Eli Lilly Launches Multi-Front War Against the Black Market for Retatrutide
Unveiling EPO’s Dark Side: Decades-Old Protein Repurposed as a Master Regulator of Cancer Immunity unveiling-epos-dark-side-decades-old-protein-repurposed-as-a-master-regulator-of-cancer-immunity

Unveiling EPO’s Dark Side: Decades-Old Protein Repurposed as a Master Regulator of Cancer Immunity

Neng Nana August 12, 2026
STANFORD, CA – April 24, 2024 – A protein long celebrated for its life-sustaining role in stimulating...
Read More Read more about Unveiling EPO’s Dark Side: Decades-Old Protein Repurposed as a Master Regulator of Cancer Immunity
Bridging the Genetic Divide: How the Broad Institute’s GaMBiT Initiative Aims to Revolutionize Drug Discovery bridging-the-genetic-divide-how-the-broad-institutes-gambit-initiative-aims-to-revolutionize-drug-discovery

Bridging the Genetic Divide: How the Broad Institute’s GaMBiT Initiative Aims to Revolutionize Drug Discovery

Neng Nana August 10, 2026
For over two decades, the scientific community has operated under a hopeful premise: that by mapping the...
Read More Read more about Bridging the Genetic Divide: How the Broad Institute’s GaMBiT Initiative Aims to Revolutionize Drug Discovery

You may have missed

a-new-dawn-for-aggressive-breast-cancers-cambridge-breakthrough-achieves-100-survival-in-landmark-trial

A New Dawn for Aggressive Breast Cancers: Cambridge Breakthrough Achieves 100% Survival in Landmark Trial

Asep Darmawan November 6, 2026
gilead-seeks-wider-use-for-livdelzi-on-phase-iii-liver-disease-success

Gilead seeks wider use for Livdelzi on Phase III liver disease success 

Lina Hope November 6, 2026
from-aspirations-to-adversity-an-international-students-journey-through-breast-cancer-and-resilience

From Aspirations to Adversity: An International Student’s Journey Through Breast Cancer and Resilience

Evan Lee Salim November 6, 2026
Young female scientist wearing lab coat and gloves carefully examining test tube with blue liquid, conducting research in modern laboratory with microscope and computer displaying dna structure

The Changing Paradigm of Metastatic Breast Cancer: From Terminal Diagnosis to Chronic Management

Siti Muinah November 6, 2026